Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 2/20 | 0.64 |
| ▸ | MTOR | P42345 | 1/20 | 0.63 |
| ▸ | ADK | P55263 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.50 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.50 |
| ▸ | SMPD3 | Q9NY59 | 1/20 | 0.49 |
| ▸ | PDE4A | P27815 | 2/20 | 0.45 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.45 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.45 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.45 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL722191 | 0.89 | NISCH (0.78) | NISCHMTORADKALDH1A1KDM4E | |
| SCHEMBL862114 | 0.86 | NISCH (0.75) | NISCHMTORADKALDH1A1KDM4E | |
| SCHEMBL9730414 | 0.84 | NISCH (0.47) | NISCHMTORADKALDH1A1KDM4E | |
| SCHEMBL6055553 | 0.83 | NISCH (0.47) | NISCHMTORADKALDH1A1KDM4E | |
| SCHEMBL6055813 | 0.83 | NISCH (0.47) | NISCHMTORADKALDH1A1KDM4E | |
| SCHEMBL29140136 | 0.81 | ALDH1A1 (0.70) | NISCHMTORADKALDH1A1KDM4E | |
| SCHEMBL28823231 | 0.80 | NISCH (0.67) | NISCHMTORADKALDH1A1KDM4E | |
| SCHEMBL8540913 | 0.80 | ESR1 (0.49) | NISCHMTORADKALDH1A1KDM4E | |
| SCHEMBL31331594 | 0.79 | NISCH (0.41) | NISCHMTORADKALDH1A1KDM4E | |
| SCHEMBL674010 | 0.78 | NISCH (1.00) | NISCHMTORADKALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 336 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4273130-B1 | PROCESS FOR SYNTHESIZING ZWITTERIONIC BASES, ZWITTERIONIC BASES, PROCESS FOR CAPTURING CO2 AND USE | PETROLEO BRASILEIRO SA PETROBRAS (BR) | 2025-12-03 | — | — | EP | claimed |
| CN-119409751-A | Ammonia decomposition reagent and application thereof in diaminopurine oligonucleotide synthesis | 中肽生化有限公司 | 2025-02-11 | — | — | CN | claimed |
| US-20240131467-A1 | PROCESS FOR SYNTHESIZING ZWITTERIONIC BASES, ZWITTERIONIC BASES, PROCESS FOR CAPTURING CO2 AND USE | PETROLEO BRASILEIRO S A – PETROBRAS (BR) | 2024-04-25 | — | — | US | claimed |
| CN-117157134-A | Method for synthesizing zwitterionic base, method for capturing CO2 and use | 巴西石油公司 | 2023-12-01 | — | — | CN | claimed |
| EP-4273130-A1 | PROCESS FOR SYNTHESIZING ZWITTERIONIC BASES, ZWITTERIONIC BASES, PROCESS FOR CAPTURING CO2 AND USE | Petróleo Brasileiro S.A. - Petrobras (BR) | 2023-11-08 | — | — | EP | claimed |
| US-RE49466-E1 | Solution phase homogeneous assays | BECKMAN COULTER, INC. (US) | 2023-03-21 | — | — | US | claimed |
| CN-113816372-B | Heteroatom-doped nitrogen-containing heterocyclic ligand derived carbon material and application thereof | 温州大学 | 2023-03-21 | — | — | CN | claimed |
| WO-2022140827-A1 | PROCESS FOR SYNTHESIZING ZWITTERIONIC BASES, ZWITTERIONIC BASES, PROCESS FOR CAPTURING CO2 AND USE | Petróleo Brasileiro S.A. - Petrobras (BR) | 2022-07-07 | — | — | WO | claimed |
| CN-113816372-A | Heteroatom-doped nitrogen-containing heterocyclic ligand derived carbon material and application thereof | 温州大学 | 2021-12-21 | — | — | CN | claimed |
| CN-112986221-A | Method for detecting substance to be detected in sample and kit thereof | 利多(香港)有限公司 | 2021-06-18 | — | — | CN | claimed |
| EP-0958287-A1 | SULFAMIDE-METALLOPROTEASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 1999-11-24 | — | — | EP | claimed |
| EP-0938677-A1 | CHEMILUMINESCENT DETECTION METHODS USING DUAL ENZYME-LABELED BINDING PARTNERS | LUMIGEN, INC. (US) | 1999-09-01 | — | — | EP | claimed |
| US-5922558-A | REACTING A PEROXIDASE ENZYME WITH A PEROXIDE AND AT LEAST ONE NOVEL COMPOUND HAVING AN ELECTRON RICH C-C DOUBLE BOND REACTIVE TO PEROXIDASE AND THE PEROXIDE TO PRODUCE AN EXCITED STATE COMPOUND; ALSO USEFUL IN ASSAYS FOR PEROXIDASE ENZYMES | LUMIGEN, INC. (US) | 1999-07-13 | — | — | US | claimed |
| WO-1999014358-A1 | CHEMILUMINESCENCE COMPOSITIONS AND METHODS | LUMIGEN, INC. (US) | 1999-03-25 | — | — | WO | claimed |
| US-5843666-A | Chemiluminescent detection methods using dual enzyer-labeled binding partners | LUMIGEN, INC. (US) | 1998-12-01 | — | — | US | claimed |
| WO-1998032748-A1 | SULFAMIDE-METALLOPROTEASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 1998-07-30 | — | — | WO | claimed |
| WO-1998021586-A1 | CHEMILUMINESCENT DETECTION METHODS USING DUAL ENZYME-LABELED BINDING PARTNERS | LUMIGEN, INC. (US) | 1998-05-22 | — | — | WO | claimed |
| CN-1034174-C | Certain imidazoquinoxalines, a new class of GABA brain receptor ligands | NEUROGEN CORP (US) | 1997-03-05 | — | — | CN | claimed |
| EP-0692033-A1 | ENHANCEMENT OF CHEMILUMINESCENT REACTIONS | BTG INTERNATIONAL LIMITED (GB) | 1996-01-17 | — | — | EP | claimed |
| CN-1076930-A | Some imidazo quinoxaline compound; The γ-An Jidingsuan brain receptor ligands that one class is new | NEUROGEN CORP (US) | 1993-10-06 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240131467-A1 | PROCESS FOR SYNTHESIZING ZWITTERIONIC BASES, ZWITTERIONIC BASES, PROCESS FOR CAPTURING CO2 AND USE | ZW10, CA2, CA4 | NISCH 566/4885MTOR 3700/4885ADK 1169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.